E-cadherin is a robust prognostic biomarker in colorectal cancer and low expression is associated with sensitivity to inhibitors of topoisomerase, aurora, and HSP90 in preclinical models
Bruun, Jarle; Eide, Peter Andreas Wold; Bergsland, Christian Holst; Brück, Oscar; Svindland, Aud; Arjama, Mariliina; Välimäki, Katja; Bjørnslett, Merete Pauline; Guren, Marianne; Kallioniemi, Olli; Nesbakken, Arild; Lothe, Ragnhild Adelheid; Pellinen, Teijo Severi
Journal article; PublishedVersion; Peer reviewed
Year
2021Permanent link
http://urn.nb.no/CRIStin
1976910Metadata
Show metadataAppears in the following Collection
- Institutt for biovitenskap [2157]
- Institutt for klinisk medisin [10714]
- CRIStin høstingsarkiv [31234]